I'm not going to register just to read the article so I'll just assume it's similar to every other lay press article about science and medicine and say that the drug is certainly promising but the Phase 3 studies to prove it's actual benefit are ongoing (I have 5 patients of mine on one of the studies). And since this is being done in hormone receptor positive breast cancer, it will be 5 to 15 years until we have actual survival data.
TL;DR: looks good. But so have lots of other drugs that didn't ultimately pan out.
This entry passed through the Full-Text RSS service - if this is your content and you're reading it on someone else's site, please read the FAQ at http://ift.tt/jcXqJW.
Neuvax thoughts?
0 commentaires:
Enregistrer un commentaire